Vivex Biomedical Revenue and Competitors
Estimated Revenue & Valuation
- Vivex Biomedical's estimated annual revenue is currently $44.8M per year.
- Vivex Biomedical's estimated revenue per employee is $193,750
- Vivex Biomedical's total funding is $14.2M.
Employee Data
- Vivex Biomedical has 231 Employees.
- Vivex Biomedical grew their employee count by -1% last year.
Vivex Biomedical's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Sales, VIVEX Biologics | Reveal Email/Phone |
2 | VP Research and Development | Reveal Email/Phone |
3 | VP Sales | Reveal Email/Phone |
4 | VP Reimbursement | Reveal Email/Phone |
5 | VP Quality Systems | Reveal Email/Phone |
6 | General Counsel | Reveal Email/Phone |
7 | VP Operations | Reveal Email/Phone |
8 | VP Sales Southeast USA | Reveal Email/Phone |
9 | VP and General Manager, Amnion and Wound Therapies | Reveal Email/Phone |
10 | VP Marketing | Reveal Email/Phone |
Vivex Biomedical Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $44.8M | 231 | -1% | $14.2M | N/A |
#2 | $43.6M | 217 | 19% | N/A | N/A |
What Is Vivex Biomedical?
Vivex Biomedical, Inc. develops Biogenic Materials from its Headquarters in Marietta, Georgia. Vivex realizes that creative treatment options and solutions that advance clinical, surgical and therapeutic patient care occur at the interface of diverse technology sectors. In a very short time, some of the brightest minds from the medical and material science industries have been assembled under the guidance of experienced and successful business professionals. The mandate is translation – ideation through clinical implementation.
keywords:N/A
$14.2M
Total Funding
231
Number of Employees
$44.8M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vivex Biomedical News
MIAMI, July 15, 2021 /PRNewswire/ -- Vivex Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatments, announced today the launch of VIA Mend™, a line of bone graft substitutes. The innovative line of bone graft substitutes can be ...
MIAMI, May 19, 2021 /PRNewswire/ -- VIVEX Biologics, Inc., a leading regenerative medicine company specializing in the development of naturally sourced treatments, announced the launch of VIAGENEX™, a family of amniotic allografts processed to retain the inherent mechanical properties of amnio ...
Vivex Biomedical, Inc., an Atlanta, Georgia-based regenerative biologics company, received a $9m line of credit. Heritage Bank of Commerce, the operating bank of Heritage Commerce Corp (NASDAQ:HTBK), provided the financing. The company will use the funds for new product development, to expand ...
Other Companies in Vinings
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $55.9M | 242 | N/A | N/A |
#2 | $39.9M | 242 | 10% | N/A |
#3 | $56.6M | 245 | -2% | N/A |
#4 | $15M | 252 | 4% | N/A |
#5 | $67.3M | 278 | 5% | N/A |